Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice
Introduction: We previously reported that the concomitant use of enalapril and telmisartan exacerbates the risk of cisplatin (CDDP)-induced acute renal dysfunction compared to other antihypertensive drugs in mice. Thus, in the current study, we investigated the risk of developing chronic kidney dise...
Main Authors: | Takumi Tsuji, Atsuki Hosoda, Yuuki Toriyama, Yuya Yoshida, Takeyuki Kohno |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523322000316 |
Similar Items
-
Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01) -
Cisplatin-induced nephrotoxicity alters blood pressure response to angiotensin II administration in rats
by: Aghdas Dehghani, et al.
Published: (2016-01-01) -
Time course of cisplatin-induced nephrotoxicity and hepatotoxicity
by: Zahra Pezeshki, et al.
Published: (2017-07-01) -
Pomegranate juice protects kidneys from Cisplatin-induced nephrotoxicity
by: Hussain A. Aljebori, et al.
Published: (2018-01-01) -
Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation
by: Hyun-Jung Kim, et al.
Published: (2015-01-01)